Skip to main content
All lobbying filings

COUNCIL FOR INNOVATION PROMOTION (C4IP)

Lobbying for COUNCIL FOR INNOVATION PROMOTION (C4IP) · A coalition dedicated to promoting strong IP rights that drive innovation.

 Filing 3rd Quarter - Report
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $90,000.00 expenses · posted Oct 20, 2025

Official filing document

 Bills named in this filing 16
  • S 2220
    Fighting for the Overlooked Recognition of Groups Operating in Toxic Test Environments in Nevada (FORGOTTEN) Veterans A…
  • HR 4370
    SAMS Act of 2025
  • S 2140
    Haskell Indian Nations University Improvement Act
  • HR 9221
    Outdoor Americans with Disabilities Act
  • S 2780
    No Tax on Large Party Tips Act
  • S 527
    Prescription Pricing for the People Act of 2025
  • S 1040
    Drug Competition Enhancement Act
  • S 1041
    Affordable Prescriptions for Patients Act
  • S 1097
    Interagency Patent Coordination and Improvement Act of 2025
  • S 1367
    NO FAKES Act of 2025
  • HR 2794
    NO FAKES Act of 2025
  • S 1095
    Stop STALLING Act
  • S 2276
    ETHIC Act
  • HR 3269
    ETHIC Act
  • S 4840
    RESTORE Patent Rights Act of 2024
  • HR 9474
    Patent Eligibility Restoration Act of 2024
 Lobbying activity 2
Copyright/Patent/Trademark

General advocacy in support of pro-IP/innovation policies S. 2220, H.R. 4370 - Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act S. 2140, H.R. 9474 - Patent Eligibility Restoration Act (PERA) Opposition to misuse of March-in provisions under the Bayh-Dole Act ITC - IP-related issues Injunctive relief for patent rights holders S. 4840, H.R. 9221 - The RESTORE Patent Rights ACT of 2024 S.2780 - The Medication Affordability and Patent Integrity Act Proposed Changes to Standard Essential Patent (SEPs) Policies S. 527, Prescription Pricing for the People Act of 2025 S. 1040, A bill to amend the Federal Trade Commission Act to prohibit product hopping, and for other purposes S. 1041, A bill to amend title 35, United States Code, to address the infringement of patents that claim biological products, and for other purposes S. 1097, Interagency Patent Coordination and Improvement Act of 2025 S.1367, H.R. 2794, No Fakes Act S. 1095. The Stop Significant and Time-Wasting Abuse Limiting Legitimate Innovation of New Generics (STALLING) Act S. 2276/H.R. 3269 Eliminating Thickets to Increase Competition Act (Ethics Act)

Trade (domestic/foreign)

General advocacy in support of pro-IP/innovation policies ITC - IP-related issues

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem